A detailed history of Mastrapasqua Asset Management Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Mastrapasqua Asset Management Inc holds 106,315 shares of ABT stock, worth $12.5 Million. This represents 1.21% of its overall portfolio holdings.

Number of Shares
106,315
Previous 105,762 0.52%
Holding current value
$12.5 Million
Previous $11.5 Million 10.7%
% of portfolio
1.21%
Previous 1.3%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 25, 2023

BUY
$95.53 - $114.62 $52,828 - $63,384
553 Added 0.52%
106,315 $10.3 Million
Q2 2023

Aug 02, 2023

SELL
$100.78 - $112.29 $89,996 - $100,274
-893 Reduced 0.84%
105,762 $11.5 Million
Q1 2023

Apr 27, 2023

BUY
$96.86 - $114.01 $104,608 - $123,130
1,080 Added 1.02%
106,655 $10.8 Million
Q4 2022

Feb 01, 2023

BUY
$95.06 - $111.52 $222,915 - $261,514
2,345 Added 2.27%
105,575 $11.6 Million
Q3 2022

Oct 27, 2022

BUY
$96.76 - $112.03 $93,953 - $108,781
971 Added 0.95%
103,230 $9.99 Million
Q2 2022

Jul 26, 2022

SELL
$102.07 - $123.37 $223,227 - $269,810
-2,187 Reduced 2.09%
102,259 $11.1 Million
Q1 2022

Apr 21, 2022

SELL
$114.02 - $139.04 $624,259 - $761,244
-5,475 Reduced 4.98%
104,446 $12.4 Million
Q4 2021

Jan 21, 2022

SELL
$115.53 - $141.46 $12,708 - $15,560
-110 Reduced 0.1%
109,921 $15.5 Million
Q3 2021

Nov 01, 2021

SELL
$116.66 - $129.06 $416,592 - $460,873
-3,571 Reduced 3.14%
110,031 $13 Million
Q2 2021

Aug 06, 2021

SELL
$105.79 - $124.53 $217,821 - $256,407
-2,059 Reduced 1.78%
113,602 $13.2 Million
Q1 2021

May 03, 2021

BUY
$108.84 - $128.23 $821,742 - $968,136
7,550 Added 6.98%
115,661 $13.9 Million
Q4 2020

Feb 02, 2021

SELL
$105.0 - $114.42 $341,670 - $372,322
-3,254 Reduced 2.92%
108,111 $11.8 Million
Q3 2020

Nov 12, 2020

SELL
$91.64 - $111.29 $58,649 - $71,225
-640 Reduced 0.57%
111,365 $12.1 Million
Q2 2020

Jul 29, 2020

SELL
$76.57 - $98.0 $1,071 - $1,372
-14 Reduced 0.01%
112,005 $10.2 Million
Q1 2020

May 08, 2020

BUY
$62.82 - $91.86 $437,541 - $639,804
6,965 Added 6.63%
112,019 $8.84 Million
Q4 2019

Feb 05, 2020

BUY
$78.51 - $87.4 $46,320 - $51,566
590 Added 0.56%
105,054 $9.13 Million
Q3 2019

Nov 12, 2019

SELL
$81.84 - $88.74 $79,466 - $86,166
-971 Reduced 0.92%
104,464 $8.74 Million
Q2 2019

Aug 12, 2019

SELL
$72.88 - $85.0 $251,727 - $293,590
-3,454 Reduced 3.17%
105,435 $8.87 Million
Q1 2019

May 14, 2019

SELL
$66.22 - $80.06 $179,389 - $216,882
-2,709 Reduced 2.43%
108,889 $8.7 Million
Q4 2018

Feb 12, 2019

SELL
$65.56 - $74.27 $109,747 - $124,327
-1,674 Reduced 1.48%
111,598 $8.07 Million
Q3 2018

Nov 15, 2018

SELL
$60.81 - $73.36 $40,377 - $48,711
-664 Reduced 0.58%
113,272 $8.31 Million
Q2 2018

Aug 13, 2018

SELL
$57.57 - $63.54 $68,162 - $75,231
-1,184 Reduced 1.03%
113,936 $6.95 Million
Q1 2018

Sep 24, 2018

BUY
$56.27 - $63.62 $277,129 - $313,328
4,925 Added 4.47%
115,120 $6.9 Million
Q4 2017

Feb 09, 2018

SELL
$53.68 - $57.47 $141,929 - $151,950
-2,644 Reduced 2.34%
110,195 $6.29 Million
Q3 2017

Nov 14, 2017

BUY
$48.06 - $53.64 $101,454 - $113,234
2,111 Added 1.91%
112,839 $6.02 Million
Q2 2017

Aug 07, 2017

BUY
N/A
110,728
110,728 $5.38 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $206B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Mastrapasqua Asset Management Inc Portfolio

Follow Mastrapasqua Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mastrapasqua Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Mastrapasqua Asset Management Inc with notifications on news.